Dataset Information

Proteomics of cyanidin 3-O-galactoside to alleviate LPS-induced inflammatory response in mammary epithelial cells of dairy goats

ABSTRACT: An in vitro mastitis cell model was constructed by treating mammary epithelial cells of dairy goats with LPS and intervening with cyanidin 3-O-galactoside as a way, to elucidate and explore the key mechanisms involved in the process of inflammation alleviation by cyanidin 3-O-galactoside.

INSTRUMENT(S):

ORGANISM(S): Capra Hircus (goat)

TISSUE(S): Epithelial Cell, Mammary Gland

DISEASE(S): Mastitis

SUBMITTER: Feng Rui

LAB HEAD: Rui Feng

PROVIDER: PXD063072 | Pride | 2025-09-15

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 11

Publications

Anthocyanins Prevent Mastitis Exacerbation by Inhibiting PANoptosis Activation.

Feng Rui R Guo Lin L Wang Fan F Zhang Qian Q Wang Guoyan G Huang Hefei H Du Wei W An Hong H Yang Yue Y Miao Henghui H Zheng Peng P Chu Tingting T Zhang Dengke D Yan Xiaoxue X Mi Xiaoyu X Ma Qian Q Gao Weilin W Li Yushan Y Li Song S Zhang Yong Y Zhu Zhenliang Z Wang Yu Y Liu Jun J Liu Xu X

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 20250624 33

Mastitis poses a huge economic burden, with antibiotics treatment leading to drug residues and the emergence of bacterial resistance. Therefore, there is an urgent need to develop alternatives to antibiotics for the treatment of mastitis. Anthocyanins (ACN) have excellent anti-inflammatory properties. However, the key pathways of mastitis disease progression and the therapeutic effects of ACN on mastitis remain poorly understood. In this study, using cows, goats, and mice as animal models, the e ...[more]

PMID: 40552401

Similar Datasets

Project description:Liposomal amphotericin B is an important frontline drug for the treatment of visceral leishmaniasis, a neglected disease of poverty. The mechanism of action of amphotericin B (AmB) is thought to involve interaction with ergosterol and other ergostane sterols, resulting in disruption of the integrity and key functions of the plasma membrane. Emergence of clinically refractory isolates of L. donovani and L. infantum is an ongoing issue and knowledge of potential resistance mechanisms can help to alleviate this problem. Here we report the characterisation of four independently selected L. donovani clones that are resistant to AmB. Whole genome sequencing revealed that in three of the moderately resistant clones, resistance was due solely to the deletion of a gene encoding C24-sterol methyltransferase (SMT1). The fourth, hyper-resistant resistant clone (>60-fold) was found to have a 24 bp deletion in both alleles of a gene encoding a putative cytochrome P450 reductase (P450R1). Metabolic profiling indicated these parasites were virtually devoid of ergosterol (0.2% versus 18% of total sterols in wild-type) and had a marked accumulation of 14-methylfecosterol (75% versus 0.1% of total sterols in wild-type) and other 14-alpha methylcholestanes. These are substrates for sterol 14-alpha demethylase (CYP51) suggesting that this enzyme is a bona fide P450R specifically involved in electron transfer from NADPH to CYP51 during catalysis. Deletion of P450R1 in wild-type cells phenocopied the metabolic changes observed in our AmB hyper-resistant clone as well as in CYP51 nulls. Likewise, addition of a wild type P450R1 gene restored sterol profiles to wild type. Our studies indicate that P450R1 is essential for L. donovani amastigote viability, thus loss of this gene is unlikely to be a driver of clinical resistance. Nevertheless, investigating the mechanisms underpinning AmB resistance in these cells provided insights that refine our understanding of the L. donovani sterol biosynthetic pathway.

			Action	DRS
	240074380-1A.raw	Raw
	240074381-1A.raw	Raw
	240074382-1A.raw	Raw
	240074383-1A.raw	Raw
	240074384-1A.raw	Raw